Cecropin vs Kalata B1 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Cecropins are a family of antimicrobial peptides first discovered in 1980 by Hans Boman in the silkmoth Hyalophora cecropia. Cecropin A was the first AMP characterized from an insect, establishing the paradigm of innate immune peptide-based defense....
Calculate Cecropin dose →Kalata B1 is the prototype cyclotide - a cyclic peptide with a head-to-tail backbone cyclization and three disulfide bonds forming a cystine knot topology. Isolated from the plant Oldenlandia affinis, which is traditionally used in Africa to accelerate childbirth (uterotonic use)...
Calculate Kalata B1 dose →| Parameter | Cecropin | Kalata B1 |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Preclinical |
| Half-Life | Minutes (proteolytic) | Hours (resistant to all proteases) |
| Typical Dose | N/A | N/A |
| Frequency | N/A | N/A |
| Route | Research only | Research only (oral stability under study) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.